These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33485094)

  • 1. Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    de Winter MA; van Es N; Büller HR; Visseren FLJ; Nijkeuter M
    Thromb Res; 2021 Mar; 199():85-96. PubMed ID: 33485094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.
    Ensor J; Riley RD; Moore D; Snell KI; Bayliss S; Fitzmaurice D
    BMJ Open; 2016 May; 6(5):e011190. PubMed ID: 27154483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
    Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
    Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.
    Khan F; Kimpton M; Tritschler T; Le Gal G; Hutton B; Fergusson DA; Rodger MA
    Syst Rev; 2019 Oct; 8(1):245. PubMed ID: 31661033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
    de Winter MA; Büller HR; Carrier M; Cohen AT; Hansen JB; Kaasjager KAH; Kakkar AK; Middeldorp S; Raskob GE; Sørensen HT; Visseren FLJ; Wells PS; Dorresteijn JAN; Nijkeuter M;
    Eur Heart J; 2023 Apr; 44(14):1231-1244. PubMed ID: 36648242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
    van Es N; Wells PS; Carrier M
    Thromb Res; 2017 Apr; 152():52-60. PubMed ID: 28237891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN; Couturaud F
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    Andras A; Sala Tenna A; Stewart M
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.
    Wang W; Su Y; Wu C; Sun Y; Dai N; Chen W; Zhang J; Xu Y; Brindis RG; Xu D; Li J
    BMC Cardiovasc Disord; 2020 Feb; 20(1):53. PubMed ID: 32013892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
    Timp JF; Braekkan SK; Lijfering WM; van Hylckama Vlieg A; Hansen JB; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2019 Oct; 16(10):e1002883. PubMed ID: 31603898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score.
    Marín-Romero S; Elías-Hernández T; Asensio-Cruz MI; Ortega-Rivera R; Morillo-Guerrero R; Toral J; Montero E; Sánchez V; Arellano E; Sánchez-Díaz JM; Real-Domínguez M; Otero-Candelera R; Jara-Palomares L
    Arch Bronconeumol (Engl Ed); 2019 Dec; 55(12):619-626. PubMed ID: 31130245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE.
    Ensor J; Riley RD; Moore D; Bayliss S; Jowett S; Fitzmaurice DA
    Syst Rev; 2013 Oct; 2():91. PubMed ID: 24089702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model.
    Tritschler T; Méan M; Limacher A; Rodondi N; Aujesky D
    Blood; 2015 Oct; 126(16):1949-51. PubMed ID: 26341256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on extended treatment for venous thromboembolism.
    Peñaloza-Martínez E; Demelo-Rodríguez P; Proietti M; Soria Fernández-Llamazares G; Llamazares-Mendo C; Álvarez-Sala Walther L; Marra AM; Del Toro-Cervera J
    Ann Med; 2018 Dec; 50(8):666-674. PubMed ID: 30345825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
    Menapace LA; McCrae KR; Khorana AA
    Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term versus extended anticoagulant treatment for unprovoked venous thromboembolism: A survey on guideline adherence and physicians' considerations.
    de Winter MA; Remme GCP; Kaasjager KHAH; Nijkeuter M
    Thromb Res; 2019 Nov; 183():49-55. PubMed ID: 31669823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.